IP Library Granted Patent US 8,765,754
Granted Patent B2
US 8,765,754 · App. 13/266,921 · Granted Jul 1, 2014

Pyrrolotriazine compounds

Inventors: Kevin J. Moriarty (East Norriton, PA); Zenon Konteatis (Chatham Township, NJ); Kristofer Moffett (Middletown, CT); Younghee Lee (Blue Bell, PA); Wenchun Chao (Portage, MI)
Assignee: Locus Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,765,754
App. No.
13/266,921
Granted
Jul 1, 2014
Kind
B2
Abstract

A compound of formula (I): wherein all symbols have the same meanings as defined in the specification; a salt thereof, a solvate thereof, an N-oxide thereof, or a prodrug thereof, has a Btk inhibitory activity, and is useful as a method for preventing and/or treating a rheumatoid arthritis, an autoimmune disease, a B cell lymphoma of cancer, and the like.

Claims (155)

1. A compound represented by formula (I)

wherein ring1 represents benzene which is optionally substituted with 1-5 substituent(s) selected from the group consisting of halogen, a C1-4 alkyl, CF 3 , nitrile, CONH 2 , and OR 5-103 ;

R 1 represents halogen or a C1-4 alkoxy;

L represents —O— or —S—;

R 2 represents (1) a C1-4 alkyl substituted with OR 5-103 , (2) C2-4 alkenyl, or (3) ring2 optionally substituted with one or more —K—R 3 ;

ring2 represents (1) a C4-7 carbocyclic ring or (2) a 4-7 membered heterocyclic ring, any atom of which is optionally substituted with one or more oxo group;

K represents bond, a C1-4 alkylene, —C(O)CH 2 —, —C(O)CH 2 CH 2 —, —C(O)O—, —CH 2 C(O)—, —CH 2 C(O)O—, —C(O)—, —CH 2 O—, —CH 2 CH 2 O—, —O—, —OCH 2 —, —OCH 2 C(O)— or —SO 2 —, wherein the left bond binds to ring2;

R 3 represents (1) hydrogen, (2) NR 3-101 R 3-102 , (3) a C1-4 alkyl optionally substituted with NR 3-101 R 3-102 , (4) a C2-4 alkenyl optionally substituted with NR 3-101 R 3-102 , (5) CF 3 , (6) nitrile, (7) halogen, or (8) a cyclic ring optionally substituted with 1-5 substituent(s) selected from the group consisting of halogen, a C1-4 alkyl, a C1-4 alkoxy, CF 3 , nitrile and oxo, wherein the cyclic ring is selected from the group consisting of morpholine, pyrrolidine, benzene, piperazine, tetrahydropyran, piperidine, tetrahydrofuran, oxazole, thiazole, pyrazole and oxadiazole;

R 4 represents (1) halogen, (2) CONR 4-101 R 4-102 , (3) CO 2 R 4-103 , (4) ring3, (5) a C1-4 alkyl which is substituted with 1-5 substituent(s) selected from ring4, nitrile, NR 4-101 R 4-102 , CONR 4-101 R 4-102 , COR 4-103 , COR 4-103 , OR 4-103 , SOR 4-103 , and SO 2 R 4-103 , or (6) a C2-4 alkenyl which is substituted with 1-5 substituent(s) selected from ring4, nitrile, NR 4-101 R 4-102 , CONR 4-101 R 4-102 , CO 2 R 4-103 , COR 4-103 , OR 4-103 , SOR 4-103 and SO 2 R 4-103 ;

R 3-101 and R 3-102 each independently represent (1) hydrogen, (2) a C1-4 alkyl, (3) COR 3-103 , (4) CONR 3-103 R 3-104 or (5) SO 2 R 3-103 , wherein R 3-103 and R 3-104 each independently represent hydrogen or a C1-4 alkyl;

R 4-101 , R 4-102 and R 4-103 each independently represent (1) hydrogen, (2) COR 5-103 , (3) NR 5-101 R 5-102 , (4) ring5, or (6) a C1-4 alkyl optionally substituted with CO 2 R 5-103 , OR 5-103 , or NR 5-101 R 5-102 ;

R 5-101 , R 5-102 and R 5-103 each independently represent hydrogen or a C1-4 alkyl;

ring3, ring4 and ring5 each independently represent a 4-7 membered heterocyclic ring optionally substituted with 1-5 substituent(s) selected from the group consisting of halogen, oxo, a C1-4 alkyl, a C1-4 alkoxy, CF 3 , CONR 5-101 R 5-102 , CO 2 R 5-103 , SOR 5-103 , SO 2 R 5-103 and nitrile;

n represents 0 or 1;

a salt thereof or a solvate thereof.

2. The compound according to claim 1 , wherein the ring2 is selected from the group consisting of cyclopentane, cyclohexane, cycloheptane, benzene, azetidine, pyrrolidine, tetrahydropyridine, piperidine, perhydroazepine, morpholine, piperazine, pyran, thiopyran, pyridine, pyrazole, isoindoline and perhydroisoquinoline.

3. The compound according to claim 1 , wherein halogen in R 4 is chlorine;

ring3 in R 4 is selected from the group consisting of pyrrolidine, piperidine, morpholine, tetrahydrothiopyran and pyridine; or

ring4 in R 4 is selected from the group consisting of pyrrolidine, piperidine, morpholine, imidazole, tetrazole and pyridine.

4. The compound according to claim 3 , wherein R 4 is (1) chlorine, (2) piperidine, (3) tetrahydrothiopyran, (4) pyrrolidine, (5) morpholine, (6) a C1-4 alkyl which is substituted with substituent(s) selected from the group consisting of NR 4-101 R 4-102 , CO 2 R 4-103 , OR 4-103 , pyrrolidine, morpholine and pyridine, or (7) a C2-4 alkenyl which is substituted with substituent(s) selected from the group consisting of NR 4-101 R 4-102 , CO 2 R 4-103 , OR 4-103 , pyrrolidine, morpholine and pyridine, wherein all the symbols have the same meanings as described in claim 1 .

5. The compound according to claim 1 , which is a compound represented by formula (I-1)

wherein ring1-1 represents benzene which may be optionally substituted with 1-5 substituent(s) selected from the group consisting of halogen, a C1-4 alkyl, CF 3 , and nitrile;

ring2-1 represents cyclopentane, cycloheptane, benzene, azetidine, tetrahydropyridine, or piperidine optionally substituted with K—R 3 ,

R 4-1 represents (1) chlorine, (2) piperidine, (3) tetrahydrothiopyran, (4) pyrrolidine, (5) morpholine (6) a C1-4 alkyl which is substituted with 1-5 substituent(s) selected from the group consisting of NR 4-101 R 4-102 , CO 2 R 4-103 , OR 4-103 , pyrrolidine, morpholine and pyridine, or (7) a C2-4 alkenyl which is substituted with 1-5 substituent(s) selected from the group consisting of NR 4-101 R 4-102 , CO 2 R 4-103 , OR 4-103 , pyrrolidine, morpholine and pyridine;

the other symbols have the same meanings as claim 1 .

6. The compound according to claim 1 , which is

(1) 5-(4-(3-chlorophenoxy)-3-methoxyphenyl)-7-(3-methoxyphenyl)-6-(3-(pyrrolidin-1-yl)propyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(2) 6-(3-(dimethylamino)propyl)-7-(3-methoxyphenyl)-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(3) 7-(3-methoxyphenyl)-5-(4-phenoxyphenyl)-6-(3-(pyrrolidin-1-yl)propyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(4) 5-(4-(3,4-dichlorophenoxy)-3-methoxyphenyl)-7-(3-methoxyphenyl)-6-(3-(pyrrolidin-1-yl)propyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(5) 5-[4-(3-chlorophenoxy)phenyl]-7-(3-methoxyphenyl)-6-(4-morpholinylmethyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(6) 5-[4-(3-chlorophenoxy)phenyl]-7-cyclopentyl-6-(4-morpholinylmethyl)pyrrolo[2,1-7f][1,2,4]triazin-4-amine,

(7) 1-(4-(4-amino-5-(4-(3,4-dichlorophenoxy)-3-methoxyphenyl)-6-(3-(pyrrolidin-1-yl)propyl)pyrrolo[2,1-f][1,2,4]triazin-7-yl)piperidin-1-yl)-2-(diethylamino)ethanone,

(8) 1-(4-(4-amino-5-(4-(3-chlorophenoxy)-3-methoxyphenyl)-6-(3-(pyrrolidin-1-yl)propyl)pyrrolo[2,1-f][1,2,4]triazin-7-yl)piperidin-1-yl)-2-(diethylamino)ethanone,

(9) 7-cyclopentyl-5-(4-(3,4-dichlorophenoxy)-3-methoxyphenyl)-6-(2-(pyridin-3-yl)ethyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(10) 7-(3-methoxyphenyl)-5-(4-phenoxyphenyl)-6-[2-(3-pyridinyl)ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(11) 5-[4-(3,4-dichlorophenoxy)phenyl]-7-(3-methoxyphenyl)-6-[2-(3-pyridinyl)ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(12) 7-(3-methoxyphenyl)-5-(4-phenoxyphenyl)-6-(piperidin-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(13) 7-cyclopentyl-5-(4-(3,4-dichlorophenoxy)-3-methoxyphenyl)-6-(piperidin-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(14) 5-(4-(3-chlorophenoxy)-3-methoxyphenyl)-7-cyclopentyl-6-(piperidin-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(15) 3-(4-(4-amino-7-cyclopentyl-6-(piperidin-4-yl)pyrrolo[2,1-f][1,2,4]triazin-5-yl)-2-methoxyphenoxy)benzonitrile,

(16) 5-[4-(3,4-dichlorophenoxy)-3-methoxy-phenyl]-7-(1-methylsulfonyl-4-piperidyl)-6-(4-piperidyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(17) 5-(4-(3-chlorophenoxy)-3-methoxyphenyl)-7-(1-(methylsulfonyl)piperidin-4-yl)-6-(piperidin-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(18) (3-{4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-6-(4-pyridinyl)pyrrolo[2,1-f][1,2,4]triazin-7-yl}phenyl)(4-methyl-1-piperazinyl)methanone,

(19) 7-cycloheptyl-5-[4-(3,4-dichlorophenoxy)-3-methoxyphenyl]-6-(4-piperidinyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(20) 5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-7-cycloheptyl-6-(4-piperidinyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(21) 5-[4-(3,4-dichlorophenoxy)-3-methoxyphenyl]-7-(3-methoxyphenyl)-6-(4-piperidinyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(22) 5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-7-(3-methoxyphenyl)-6-(4-piperidinyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(23) N-(4-{4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-6-(4-piperidinyl)pyrrolo[2,1-f][1,2,4]triazin-7-yl}phenyl)-N-methylmethanesulfonamide,

(24) 5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-7-(4-methoxyphenyl)-6-(4-piperidinyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(25) N-(4-{4-amino-5-[4-(3,4-dichlorophenoxy)-3-methoxyphenyl]-6-(4-piperidinyl)pyrrolo[2,1-f][1,2,4]triazin-7-yl}phenyl)-N-methylmethanesulfonamide,

(26) 3-{4-[4-amino-7-(4-methoxyphenyl)-6-(4-piperidinyl)pyrrolo[2,1-f][1,2,4]triazin-5-yl]-2-methoxyphenoxy}benzonitrile,

(27) 6-chloro-5-(4-(3-chlorophenoxy)-3-methoxyphenyl)-7-(1-(methylsulfonyl)piperidin-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(28) 1-(3-(4-amino-6-chloro-5-(4-(3-chlorophenoxy)-3-methoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-7-yl)piperidin-1-yl)prop-2-en-1-one,

(29) 1-(3-(4-amino-6-chloro-5-(4-(3,4-dichlorophenoxy)-3-methoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-7-yl)piperidin-1-yl)prop-2-en-1-one,

(30) 5-(4-(3-chlorophenoxy)-3-methoxyphenyl)-7-cyclopentyl-6-(pyrrolidin-3-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(31) 5-[4-(3-chlorophenoxy)phenyl]-7-cyclopentyl-6-(2-ethoxyethyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(32) 3-{4-amino-5-[4-(3,4-dichlorophenoxy)-3-methoxyphenyl]-7-(3-methoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(33) {4-amino-7-cyclopentyl-5-[4-(3,4-dichlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}acetic acid,

(34) 2-{4-amino-7-cyclopentyl-5-[4-(3,4-dichlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}ethanol,

(35) methyl 4-amino-7-(3-methoxyphenyl)-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazine-6-carboxylate,

(36) 4-amino-7-(3-methoxyphenyl)-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazine-6-carboxylic acid,

(37) ethyl 3-{7-(1-acryloyl-3-piperidinyl)-4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoate,

(38) 4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazine-6-carboxylic acid,

(39) 3-{4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-7-(1-propen-2-yl)pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(40) (2E)-3-[4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]acrylonitrile,

(41) methyl ({[4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]carbonyl}amino)acetate,

(42) 6-fluoro-7-(3-methoxyphenyl)-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(43) ethyl (2E)-3-[7-(1-acryloyl-3-methoxy-3-azetidinyl)-4-amino-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]acrylate,

(44) 3-[4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]-2-methylacrylic acid,

(45) (2E)-3-{4-amino-7-cyclopentyl-5-[4-(3,4-dichlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}acrylic acid,

(46) (2E)-3-[4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]acrylamide,

(47) (2E)-3-[4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]-2-propen-1-ol,

(48) 6-(2-aminoethyl)-7-cyclopentyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(49) (2E)-3-[4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]acrylohydrazide,

(50) 3-{4-amino-5-[4-(3,4-dichlorophenoxy)-3-methoxyphenyl]-7-(3-methoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanamide,

(51) (2E)-1-(3-[4-amino-6-chloro-5-[4-(3,4-dichlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl]-1-piperidinyl)-4-(dimethylamino)-2-buten-1-one,

(52) 1-(3-{4-amino-6-chloro-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl}-1-pyrrolidinyl)-2-propen-1-one,

(53) 3-{7-(1-acryloyl-3-piperidinyl)-4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(54) 3-{4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-7-cyclopentylpyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(55) 4-{4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-7-(3-methoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl}butanoic acid,

(56) 4-{4-amino-5-[4-(3,4-dichlorophenoxy)-3-methoxyphenyl]-7-(3-methoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl}butanoic acid,

(57) 3-(4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-7-{4-[(methylsulfonyl)amino]phenyl}pyrrolo[2,1-f][1,2,4]triazin-6-yl)propanoic acid,

(58) (2E)-3-[4-amino-7-(3-methoxyphenyl)-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]acrylic acid,

(59) 1-(3-{4-amino-6-chloro-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl}-3-methoxy-1-azetidinyl)-2-propen-1-one,

(60) 5-[4-(3,4-dichlorophenoxy)-3-methoxyphenyl]-7-(3-methoxyphenyl)-6-[2-(1H-tetrazol-5-yl)ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(61) 3-{4-amino-5-[4-(3-chlorophenoxy)phenyl]-7-cyclopentylpyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(62) 3-{4-amino-7-cyclopentyl-5-[4-(3,4-dichlorophenoxy)phenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(63) 3-[4-amino-7-cyclopentyl-5-{4-(3,4-dichlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(64) 3-(4-amino-7-cyclopentyl-5-{4-[3-(2-propanyl)phenoxy]phenyl}pyrrolo[2,1-f][1,2,4]triazin-6-yl)propanoic acid,

(65) 3-{7-(1-acryloyl-1,2,5,6-tetrahydro-3-pyridinyl)-4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(66) 3-[4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]propanoic acid,

(67) 3-[4-amino-7-cyclopentyl-5-(3-hydroxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]propanoic acid,

(68) 1-(3-{4-amino-6-chloro-5-[4-(3-chlorophenoxy)-3-hydroxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl}-1-piperidinyl)-2-propen-1-one,

(69) 3-{4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-7-(3-methoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(70) 3-{4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-7-(4-methoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(71) 3-{7-(1-acryloyl-3-piperidinyl)-4-amino-5-[4-(3,4-dichlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(72) 3-{4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-7-phenylpyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(73) 3-{4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-7-(2-fluorophenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(74) 3-{4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-7-(3-fluorophenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(75) 3-{4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-7-(4-fluorophenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(76) 3-{4-amino-7-cyclopentyl-5-[4-(3,5-difluorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(77) 3-{4-amino-7-cyclopentyl-5-[4-(3,5-dichlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(78) 3-{4-amino-7-(3-carbamoylphenyl)-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(79) 3-{4-amino-7-cyclopentyl-5-[4-(3,5-difluorophenoxy)phenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(80) 3-{4-amino-7-cyclopentyl-5-[4-(3,5-dichlorophenoxy)phenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(81) (2E)-3-[4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]acrylic acid,

(82) 3-{4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-7-(2-hydroxy-2-propanyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(83) ({[4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]carbonyl}amino)acetic acid,

(84) 3-(4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-7-{4-[methyl(methylsulfonyl)amino]phenyl}pyrrolo[2,1-f][1,2,4]triazin-6-yl)propanoic acid,

(85) 3-{4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-7-[4-(methylsulfonyl)phenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(86) 1-[5-{4-amino-6-chloro-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl}-3,6-dihydro-1(2H)-pyridinyl]-2-propen-1-one,

(87) 3-[4-amino-7-{4-[methyl(methylsulfonyl)amino]phenyl}-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]propanoic acid,

(88) (2E)-3-[4-amino-7-(2-hydroxy-2-propanyl)-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]acrylic acid,

(89) 3-(4-amino-7-cyclopentyl-5-{3-methoxy-4-[3-(2-propanyl)phenoxy]phenyl}pyrrolo[2,1-f][1,2,4]triazin-6-yl)propanoic acid,

(90) (2E)-3-[7-(1-acryloyl-3-methoxy-3-azetidinyl)-4-amino-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]acrylic acid,

(91) (2E)-3-{4-amino-7-[1-(methylsulfonyl)-4-piperidinyl]-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl}acrylic acid,

(92) (2E)-3-[4-amino-7-cyclopentyl-5-(2-fluoro-4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]acrylic acid,

(93) 3-[4-amino-7-(3-methoxyphenyl)-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]propanoic acid,

(94) (2E)-3-[4-amino-7-cyclohexyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]acrylic acid,

(95) (2E)-3-[4-amino-7-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]acrylic acid,

(96) (2E)-3-(4-amino-7-cyclopentyl-5-{4-[3-(2-propanyl)phenoxy]phenyl}pyrrolo[2,1-f][1,2,4]triazin-6-yl)acrylic acid,

(97) (2E)-3-{4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]-7-cyclopentylpyrrolo[2,1-f][1,2,4]triazin-6-yl}acrylic acid,

(98) (2E)-3-[4-amino-5-(4-phenoxyphenyl)-7-(tetrahydro-2H-pyran-4-yl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]acrylic acid,

(99) (2E)-3-[4-amino-7-(3-hydroxy-3-methylbutyl)-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]acrylic acid,

(100) (2E)-3-[4-amino-7-isopropyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]acrylic acid,

(101) N-{2-[4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]ethyl}acetamide,

(102) 1-[4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]-1,2-ethanediol,

(103) 4-[4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]-1-hydroxy-2-butanone,

(104) 4-amino-7-cyclopentyl-N-(2-hydroxyethyl)-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazine-6-carboxamide,

(105) 4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)-N-(1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazine-6-carboxamide,

(106) 4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)-N-(1H-pyrazol-3-yl)pyrrolo[2,1-f][1,2,4]triazine-6-carboxamide,

(107) (2E)-3-[4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]acrylamide,

(108) 4-amino-7-cyclopentyl-N-(2-methoxyethyl)-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazine-6-carboxamide,

(109) 4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazine-6-carbohydrazide,

(110) 4-amino-7-cyclopentyl-N-[2-(dimethylamino)ethyl]-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazine-6-carboxamide,

(111) (2E)-3-[4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]-N-(1H-pyrazol-4-yl)acrylamide, or

(112) 4-amino-7-cyclopentyl-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazine-6-carboxamide.

7. The compound according to claim 1 , which is

(1) 5-(4-(3,4-dichlorophenoxy)-3-methoxyphenyl)-7-(3-methoxyphenyl)-6-(3-(pyrrolidin-1-yl)propyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(2) 5-(4-(3-chlorophenoxy)-3-methoxyphenyl)-7-(3-methoxyphenyl)-6-(3-(pyrrolidin-1-yl)propyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(3) 7-cycloheptyl-5-(4-(3,4-dichlorophenoxy)-3-methoxyphenyl)-6-(piperidin-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine,

(4) 1-(3-(4-amino-6-chloro-5-(4-(3-chlorophenoxy)-3-methoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-7-yl)piperidin-1-yl)prop-2-en-1-one,

(5) 1-(3-(4-amino-6-chloro-5-(4-(3,4-dichlorophenoxy)-3-methoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-7-yl)piperidin-1-yl)prop-2-en-1-one,

(6) ethyl 3-{7-(1-acryloyl-3-piperidinyl)-4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoate,

(7) ethyl (2E)-3-[7-(1-acryloyl-3-methoxy-3-azetidinyl)-4-amino-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]acrylate,

(8) 1-(3-[4-amino-6-chloro-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl]-1-pyrrolidinyl)-2-propen-1-one,

(9) 3-{7-(1-acryloyl-3-piperidinyl)-4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(10) 1-(3-{4-amino-6-chloro-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl}-3-methoxy-1-azetidinyl)-2-propen-1-one,

(11) 3-{7-(1-acryloyl-1,2,5,6-tetrahydro-3-pyridinyl)-4-amino-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(12) 3-{7-(1-acryloyl-3-piperidinyl)-4-amino-5-[4-(3,4-dichlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl}propanoic acid,

(13) 1-[5-{4-amino-6-chloro-5-[4-(3-chlorophenoxy)-3-methoxyphenyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl}-3,6-dihydro-1(2H)-pyridinyl]-2-propen-1-one, or

(14) (2E)-3-[7-(1-acryloyl-3-methoxy-3-azetidinyl)-4-amino-5-(4-phenoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]acrylic acid.

8. A compound of formula (I) of claim 1 , a salt thereof or a solvate thereof, for preventing and/or treating a Btk related disease.

9. A pharmaceutical composition comprising the compound represented by formula (I) of claim 1 , a salt thereof or a solvate thereof.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS OF ASSIGNEE PREVIOUSLY RECORDED ON REEL 028090 FRAME 0129. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNOR'S INTEREST. Recorded May 2, 2012
From: WONG (LEGAL REPRESENTATIVE OF KEVIN J. MORIARTY), DORA DO-YORK; KONTEATIS, ZENON; MOFFETT, KRISTOFER; LEE, YOUNGHEE; CHAO, WENCHUN
To: LOCUS PHARMACEUTICALS, INC.
Reel/Frame 028141/0374 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2012
From: WONG (LEGAL REPRESENTATIVE OF KEVIN J. MORIARTY), DORA DO-YORK; KONTEATIS, ZENON; MOFFETT, KRISTOFER; LEE, YOUNGHEE; CHAO, WENCHUN
To: LOCUS PHARMACEUTICALS, INC.
Reel/Frame 028090/0129 →
Continuity (2)
Provisional Application 61173869 · Apr 29, 2009
Related Publication 20120232054A1 · Sep 13, 2012